Article
Evolution of cell therapy for renal cell carcinoma
9 Jan 2024
Abstract excerpt
Treatment for renal cell carcinoma (RCC) has improved dramatically over the last decade, shifting from high-dose cytokine therapy in combination with surgical resection of tumors to targeted therapy, immunotherapy, and combination therapies. However, curative treatment, particularly for advanced-stage disease, remains rare. Cell therapy as a "living drug" has achieved hematological malignancy cures with a high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
